
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (11): 1422-1429.DOI: 10.12114/j.issn.1007-9572.2025.0200
• Original Research • Previous Articles
Received:2025-04-10
Revised:2025-09-30
Published:2026-04-15
Online:2026-03-12
Contact:
LI Pengfei
通讯作者:
李鹏飞
作者简介:作者贡献:
刘洋负责研究的实施、撰写论文;梁芳、吴玲负责数据的收集与整理、统计学处理;李文磊负责论文的修订与结果的解释;李鹏飞负责研究的构思与设计、文章的质量控制与审查、对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2025.0200
| 组别 | 例数 | 年龄( | 性别(男/女) | 高血压病史[例(%)] | 糖尿病病史[例(%)] | 心房颤动病史[例(%)] | 高脂血症病史[例(%)] | TC[M(P25,P75),mmol/L] | TG[M(P25,P75),mmol/L] | LDL-C[M(P25,P75),mmol/L] |
|---|---|---|---|---|---|---|---|---|---|---|
| 对照组 | 709 | 69.0±8.1 | 386/323 | 440(62.06) | 72(10.16) | 11(1.55) | 40(5.64) | 4.40(3.93,4.87) | 1.02(0.76,1.43) | 2.44(2.07,2.83) |
| 卒中组 | 313 | 67.8±12.6 | 198/115 | 218(69.65) | 102(32.59) | 34(10.86) | 33(10.54) | 4.40(3.71,5.42) | 1.27(0.98,1.90) | 2.54(2.10,3.21) |
| 检验统计量值 | 1.60a | 2.00b | 5.45b | 77.35b | 44.72b | 7.87b | 0.74 | 6.57 | 2.50 | |
| P值 | 0.11 | 0.16 | 0.02 | <0.01 | <0.01 | <0.01 | 0.46 | <0.01 | 0.46 | |
| 组别 | HDL-C[M(P25,P75),mmol/L] | RC[M(P25,P75),mmol/L] | TyG指数[M(P25,P75)] | TG/HDL-C[M(P25,P75)] | non-HDL-C[M(P25,P75),mmol/L] | FPG[M(P25,P75),mmol/L] | PLT[M(P25,P75),×109/L] | PHR [M(P25,P75)] | ||
| 对照组 | 1.32(1.14,1.49) | 0.60(0.43,0.79) | 8.33(7.99,8.74) | 0.78(0.55,1.17) | 3.06(2.58,3.49) | 4.97(4.64,5.45) | 214.0(179.0,249.0) | 157.7(125.5,192.0) | ||
| 卒中组 | 1.16(0.97,1.36) | 0.65(0.46,0.88) | 8.78(8.42,9.20) | 1.18(0.74,1.73) | 3.21(2.64,4.12) | 5.86(5.03,7.61) | 204.0(167.0,236.0) | 171.8(135.0,223.6) | ||
| 检验统计量值 | 7.50 | 2.88 | 9.55 | 8.02 | 3.00 | 10.67 | 2.70 | 4.18 | ||
| P值 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 |
Table 1 Comparison of baseline data between the two groups
| 组别 | 例数 | 年龄( | 性别(男/女) | 高血压病史[例(%)] | 糖尿病病史[例(%)] | 心房颤动病史[例(%)] | 高脂血症病史[例(%)] | TC[M(P25,P75),mmol/L] | TG[M(P25,P75),mmol/L] | LDL-C[M(P25,P75),mmol/L] |
|---|---|---|---|---|---|---|---|---|---|---|
| 对照组 | 709 | 69.0±8.1 | 386/323 | 440(62.06) | 72(10.16) | 11(1.55) | 40(5.64) | 4.40(3.93,4.87) | 1.02(0.76,1.43) | 2.44(2.07,2.83) |
| 卒中组 | 313 | 67.8±12.6 | 198/115 | 218(69.65) | 102(32.59) | 34(10.86) | 33(10.54) | 4.40(3.71,5.42) | 1.27(0.98,1.90) | 2.54(2.10,3.21) |
| 检验统计量值 | 1.60a | 2.00b | 5.45b | 77.35b | 44.72b | 7.87b | 0.74 | 6.57 | 2.50 | |
| P值 | 0.11 | 0.16 | 0.02 | <0.01 | <0.01 | <0.01 | 0.46 | <0.01 | 0.46 | |
| 组别 | HDL-C[M(P25,P75),mmol/L] | RC[M(P25,P75),mmol/L] | TyG指数[M(P25,P75)] | TG/HDL-C[M(P25,P75)] | non-HDL-C[M(P25,P75),mmol/L] | FPG[M(P25,P75),mmol/L] | PLT[M(P25,P75),×109/L] | PHR [M(P25,P75)] | ||
| 对照组 | 1.32(1.14,1.49) | 0.60(0.43,0.79) | 8.33(7.99,8.74) | 0.78(0.55,1.17) | 3.06(2.58,3.49) | 4.97(4.64,5.45) | 214.0(179.0,249.0) | 157.7(125.5,192.0) | ||
| 卒中组 | 1.16(0.97,1.36) | 0.65(0.46,0.88) | 8.78(8.42,9.20) | 1.18(0.74,1.73) | 3.21(2.64,4.12) | 5.86(5.03,7.61) | 204.0(167.0,236.0) | 171.8(135.0,223.6) | ||
| 检验统计量值 | 7.50 | 2.88 | 9.55 | 8.02 | 3.00 | 10.67 | 2.70 | 4.18 | ||
| P值 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 |
| 自变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| TG | -0.595 | 0.354 | 2.817 | 0.093 | 0.552(0.276~1.105) |
| FPG | 0.253 | 0.080 | 10.018 | 0.002 | 1.288(1.101~1.506) |
| TyG指数 | 0.997 | 0.419 | 5.660 | 0.017 | 2.710(1.192~6.160) |
| RC | -0.191 | 0.185 | 1.062 | 0.303 | 0.826(0.575~1.188) |
| non-HDL-C | 0.042 | 0.112 | 0.138 | 0.710 | 1.043(0.837~1.299) |
| PHR | 0.003 | 0.002 | 4.099 | 0.043 | 1.003(1.000~1.006) |
| TG/HDL-C | 0.568 | 0.273 | 4.328 | 0.037 | 1.765(1.033~3.014) |
Table 2 Multivariate Logistic regression analysis of influencing factors for acute ischemic stroke
| 自变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| TG | -0.595 | 0.354 | 2.817 | 0.093 | 0.552(0.276~1.105) |
| FPG | 0.253 | 0.080 | 10.018 | 0.002 | 1.288(1.101~1.506) |
| TyG指数 | 0.997 | 0.419 | 5.660 | 0.017 | 2.710(1.192~6.160) |
| RC | -0.191 | 0.185 | 1.062 | 0.303 | 0.826(0.575~1.188) |
| non-HDL-C | 0.042 | 0.112 | 0.138 | 0.710 | 1.043(0.837~1.299) |
| PHR | 0.003 | 0.002 | 4.099 | 0.043 | 1.003(1.000~1.006) |
| TG/HDL-C | 0.568 | 0.273 | 4.328 | 0.037 | 1.765(1.033~3.014) |
| 自变量 | rs值 | P值 |
|---|---|---|
| TyG指数 | 0.148 | 0.012 |
| TG/HDL-C | 0.140 | 0.017 |
| TG | 0.119 | 0.044 |
| PHR | 0.043 | 0.467 |
| FPG | 0.039 | 0.505 |
Table 3 Spearman's rank correlation analysis of TyG index, TG/HDL-C ratio, TG, PHR, FPG levels, and NIHSS scores
| 自变量 | rs值 | P值 |
|---|---|---|
| TyG指数 | 0.148 | 0.012 |
| TG/HDL-C | 0.140 | 0.017 |
| TG | 0.119 | 0.044 |
| PHR | 0.043 | 0.467 |
| FPG | 0.039 | 0.505 |
| 项目 | AUC | 95%CI | P值 | 最佳截断值 | 约登指数 | 灵敏度 | 特异度 |
|---|---|---|---|---|---|---|---|
| TyG指数 | 0.712 | 0.675~0.749 | 0.019 | 8.416 | 0.326 | 0.753 | 0.574 |
| TG/HDL-C | 0.674 | 0.635~0.712 | 0.020 | 0.955 | 0.272 | 0.633 | 0.640 |
| TG | 0.646 | 0.607~0.686 | 0.020 | 1.035 mmol/L | 0.227 | 0.710 | 0.517 |
| PHR | 0.588 | 0.546~0.630 | 0.021 | 223.37 | 0.153 | 0.254 | 0.898 |
| FPG | 0.723 | 0.685~0.762 | 0.019 | 5.505 mmol/L | 0.381 | 0.608 | 0.774 |
| TyG指数+FPG+TG+TG/HDL-C | 0.762 | 0.728~0.797 | 0.018 | 0.362 | 0.426 | 0.640 | 0.787 |
| TyG指数+FPG | 0.751 | 0.716~0.786 | 0.018 | 0.289 | 0.403 | 0.760 | 0.643 |
| FPG+TG | 0.750 | 0.714~0.785 | 0.018 | 0.338 | 0.432 | 0.740 | 0.693 |
| FPG+TG/HDL-C | 0.761 | 0.726~0.796 | 0.018 | 0.290 | 0.450 | 0.767 | 0.683 |
| TyG指数+TG/HDL-C | 0.724 | 0.688~0.760 | 0.018 | 0.333 | 0.357 | 0.689 | 0.668 |
| TyG指数+TG | 0.741 | 0.705~0.776 | 0.018 | 0.304 | 0.394 | 0.777 | 0.617 |
| TyG指数+TG+FPG | 0.751 | 0.716~0.786 | 0.018 | 0.285 | 0.404 | 0.781 | 0.623 |
| FPG+PHR | 0.740 | 0.702~0.778 | 0.019 | 0.314 | 0.438 | 0.721 | 0.717 |
| FPG+TyG指数+PHR | 0.757 | 0.722~0.792 | 0.018 | 0.338 | 0.432 | 0.693 | 0.740 |
| FPG+TG/HDL-C+TyG指数 | 0.759 | 0724~0.794 | 0.018 | 0.299 | 0.417 | 0.746 | 0.672 |
| TyG指数+FPG+TG/HDL-C+PHR+TG | 0.762 | 0.728~0.797 | 0.018 | 0.306 | 0.441 | 0.735 | 0.706 |
Table 4 Diagnostic performance of different parameters and their combinations for acute ischemic stroke
| 项目 | AUC | 95%CI | P值 | 最佳截断值 | 约登指数 | 灵敏度 | 特异度 |
|---|---|---|---|---|---|---|---|
| TyG指数 | 0.712 | 0.675~0.749 | 0.019 | 8.416 | 0.326 | 0.753 | 0.574 |
| TG/HDL-C | 0.674 | 0.635~0.712 | 0.020 | 0.955 | 0.272 | 0.633 | 0.640 |
| TG | 0.646 | 0.607~0.686 | 0.020 | 1.035 mmol/L | 0.227 | 0.710 | 0.517 |
| PHR | 0.588 | 0.546~0.630 | 0.021 | 223.37 | 0.153 | 0.254 | 0.898 |
| FPG | 0.723 | 0.685~0.762 | 0.019 | 5.505 mmol/L | 0.381 | 0.608 | 0.774 |
| TyG指数+FPG+TG+TG/HDL-C | 0.762 | 0.728~0.797 | 0.018 | 0.362 | 0.426 | 0.640 | 0.787 |
| TyG指数+FPG | 0.751 | 0.716~0.786 | 0.018 | 0.289 | 0.403 | 0.760 | 0.643 |
| FPG+TG | 0.750 | 0.714~0.785 | 0.018 | 0.338 | 0.432 | 0.740 | 0.693 |
| FPG+TG/HDL-C | 0.761 | 0.726~0.796 | 0.018 | 0.290 | 0.450 | 0.767 | 0.683 |
| TyG指数+TG/HDL-C | 0.724 | 0.688~0.760 | 0.018 | 0.333 | 0.357 | 0.689 | 0.668 |
| TyG指数+TG | 0.741 | 0.705~0.776 | 0.018 | 0.304 | 0.394 | 0.777 | 0.617 |
| TyG指数+TG+FPG | 0.751 | 0.716~0.786 | 0.018 | 0.285 | 0.404 | 0.781 | 0.623 |
| FPG+PHR | 0.740 | 0.702~0.778 | 0.019 | 0.314 | 0.438 | 0.721 | 0.717 |
| FPG+TyG指数+PHR | 0.757 | 0.722~0.792 | 0.018 | 0.338 | 0.432 | 0.693 | 0.740 |
| FPG+TG/HDL-C+TyG指数 | 0.759 | 0724~0.794 | 0.018 | 0.299 | 0.417 | 0.746 | 0.672 |
| TyG指数+FPG+TG/HDL-C+PHR+TG | 0.762 | 0.728~0.797 | 0.018 | 0.306 | 0.441 | 0.735 | 0.706 |
| [1] |
姚涛,田柏淋,湛彦强, 等. 急性缺血性脑卒中患者体质量指数与临床预后及病死率的相关性[J]. 实用医学杂志, 2019, 35(20): 3188-3192.
|
| [2] |
|
| [3] |
王前友,赵博轩,王文安. 1990—2019年中国缺血性脑卒中发病和死亡趋势及年龄-时期-队列模型分析[J]. 中华全科医学, 2024, 22(6): 1059-1063. DOI: 10.16766/j.cnki.issn.1674-4152.003566.
|
| [4] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,彭斌, 等. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. DOI: 10.3760/cma.j.issn.1006-7876.2018.09.004.
|
| [5] |
张乐乐,吴嘉,汪俊军. 缺血性脑卒中二级预防中的血液生物标志物[J]. 临床检验杂志, 2022, 40(10): 783-786. DOI: 10.13602/j.cnki.jcls.2022.10.15.
|
| [6] |
方兴,江颖,欧俐羽, 等. 脑梗死患者同型半胱氨酸与血脂相关性及其诊断价值[J]. 实用医学杂志, 2017, 33(22): 3819-3821.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [1] | LI Qiuchun, SU Ping, PANG Jinhong, CHEN Qiaoqiao, ZHAO Yingying, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association of Triglyceride Glucose Index with Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(09): 1129-1136. |
| [2] | CAO Lei, LIU Xuechun, JIANG Wei, CHEN Yan, YAN Sunhong, DU Jing. Study on the Prediction of Muscle Attenuation in Patients with Acute Ischemic Stroke by the Cross-sectional Area and Thickness of the Temporalis Muscle [J]. Chinese General Practice, 2026, 29(08): 997-1007. |
| [3] | FAN Xueming, YANG Ningning, ZHENG Zheng, WU Yumei, WANG Qi. Analysis of Correlation Factors and Predictive Value of Microvascular Complications in Patients with Type 2 Diabetes Mellitus Combined with Metabolic-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(36): 4578-4585. |
| [4] | MI Lingyu, CHEN Lianxin, GAO Hengbo, WANG Bincheng. Predictive Value of Triglyceride-glucose Index for Prognosis in Patients with Pulmonary Embolism [J]. Chinese General Practice, 2025, 28(35): 4421-4429. |
| [5] | LIU Xiaoxue, LYU Liang, FENG Wanting, YANG Huifang, TENG Yilin, MA Tianpei, ZHANG Tao, JIANG Xia, LONG Lu, LIAO Jiaqiang, FAN Mengyu, WANG Chuan, YANG Dailan, LI Jiayuan, ZHANG Ben. Association of Longitudinal Trajectories of Triglyceride-glucose Index and Liver Stiffness Status in Elderly People [J]. Chinese General Practice, 2025, 28(29): 3668-3673. |
| [6] | HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284. |
| [7] | CHEN Qiaoqiao, SU Ping, ZHAO Yingying, PANG Jinhong, SHI Jie, WANG Yaqian, LI Qiuchun, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association between Triglyceride-Glucose Index and Incident Cardiometabolic Multimorbidity in the Elderly: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2270-2277. |
| [8] | LIU Zuting, XU Minghuan, YANG Xuezhi, MO Jiali, LIU Xingyu, DU Huijie, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between the Systemic Inflammatory Response Index and Risk of Ischemic Stroke Recurrence [J]. Chinese General Practice, 2025, 28(05): 541-547. |
| [9] | DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560. |
| [10] | YUAN Dan, WANG Ying, WANG Yingpeng, XU Li, XUE Jia, CHENG Jingjing, WANG Haipeng. Effect of the Remote Ischemic Postconditioning on the Prognosis of Patients with Acute Ischemic Stroke beyond Time Window: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(02): 169-174. |
| [11] | LIU Xingyu, DU Huijie, MO Jiali, XU Minghuan, LIU Zuting, YANG Xuezhi, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between Remnant Cholesterol and the Risk of Ischemic Stroke Recurrence and Its Predictive Value [J]. Chinese General Practice, 2024, 27(26): 3227-3231. |
| [12] | SU Ziwei, MA Yan, ZHOU Yanzhang, ZHOU Zhiliang. Advances in Traditional Chinese Medicine Regulating Mitochondrial Quality Control in the Treatment of Ischemic Stroke [J]. Chinese General Practice, 2024, 27(24): 3023-3030. |
| [13] | HOU Qinchuan, ZHANG Rui, LI Binghong, ZHANG Huiwang, ZHANG Beibei, YONG Tao, LIU Yuping, SHUAI Ping. A Retrospective Cohort Study on the Relationship between Triglyceride-Glucose Index and Its Combination with Obesity Indices and Chronic Kidney Disease in Adults [J]. Chinese General Practice, 2024, 27(22): 2731-2738. |
| [14] | NIU Jingyuan, CHEN Huisheng, YU Jiaxiang, CUI Yu. Ligustrazine Injection in the Treatment of Acute Ischemic Stroke: a Bayesian Network Meta-analysis [J]. Chinese General Practice, 2024, 27(14): 1761-1774. |
| [15] | XIE Yi, XU Junma, XU Fangqin, LI Chao, CHEN Chen, SHAO Chan. Predictive Value of Sarcopenia Index for Prognosis in Elderly Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2024, 27(11): 1326-1330. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||